Posted July 10, 2020
Writing in the prestigious New England Journal of Medicine, Stanford Law School and Health Policy departments propose priority vaccination for high-risk groups that comprise the population that are least likely to benefit and most likely to experience side effects and hospitalization from COVID-19 coronavirus immunization, or from any vaccine for that matter. Read more.